ZEB1 Defines the Interaction Between Breast Cancer Cells and Macrophages by Upregulating the Expression of CCL2 Cytokine
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27209194 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Oleg Semenov und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cytology of the Russian Academy of Sciences, St. Petersburg 194064, Russia. Hauptthemen laut MEDLINE: Zinc Finger E-box-Binding Homeobox 1, Chemokine CCL2, Breast Neoplasms, Macrophages. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Committee of Science of the Ministry of Science and Higher Education of the Republic of Kazakhstan, Nazarbayev University, RSF.
Abstract (Originalsprache)
The survival of disseminating tumor cells at the invasive edge and in metastatic foci depends on their ability to counteract anti-tumor immunity. The epithelial–mesenchymal transition (EMT) process is associated with the recruitment of immune-suppressive myeloid cells. The onset of the EMT gene expression program is controlled by several transcriptional master-regulators, including ZEB1. Using engineered breast cancer cell lines with different statuses of ZEB1, we examined the effects of ZEB1 on the expression of different pro-inflammatory cytokines. Our results suggest that ZEB1 plays an important role in regulating the expression of CCL2 (C-C motif ligand 2, a.k.a. MCP-1), the main chemoattractant of monocytes. Forced expression of ZEB1 in epithelial MCF-7 cells significantly increased the expression level of CCL2, which was further enhanced by TNF-α. On the contrary, knock-out of ZEB1 in pseudo-mesenchymal MDA-MB-231 cells led to a complete loss of CCL2 expression. Moreover, this effect was not restored by TNF-α induction. Also, positive ZEB1 status in breast cancer cells promoted the chemoattraction of THP-1 macrophages in co-culture experiments. Analysis of publicly available ChIP-seq data implicated ZEB1 in the regulation of CCL2 gene transcription. Taken together, these data suggest that ZEB1 is involved in the formation of the EMT-associated pro-tumor immune microenvironment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Cytology of the Russian Academy of Sciences, St. Petersburg 194064, Russia.
- Department of Biomedical sciences, School of Medicine, Nazarbayev University, Astana 010000, Kazakhstan.
- National Laboratory of Astana, Astana 010000, Kazakhstan.
ORCID-Profile: Oleg Semenov, Ivan Nevzorov, Sergei Silonov, Alexandra Daks, Aliya Kabasheva, Alexander Nazarov, Daria Kriger, Ivan Kuneev, Yulia Gnennaya, Oleg Shuvalov, Nickolai Barlev
Förderung
- Committee of Science of the Ministry of Science and Higher Education of the Republic of Kazakhstan
- Nazarbayev University
- RSF
- CRP
Zitieren
APA
Semenov, O., Nevzorov, I., Silonov, S., Daks, A., Kabasheva, A., Nazarov, A., Kriger, D., Kuneev, I., Petukhov, A., Gnennaya, Y., Tulchinsky, E., Shuvalov, O., & Barlev, N. (2026). ZEB1 Defines the Interaction Between Breast Cancer Cells and Macrophages by Upregulating the Expression of CCL2 Cytokine. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27209194
Vancouver
Semenov O, Nevzorov I, Silonov S, Daks A, Kabasheva A, Nazarov A, et al. ZEB1 Defines the Interaction Between Breast Cancer Cells and Macrophages by Upregulating the Expression of CCL2 Cytokine. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27209194
BibTeX
@article{Semenov2026,
author = {Semenov, Oleg and Nevzorov, Ivan and Silonov, Sergei and Daks, Alexandra and Kabasheva, Aliya and Nazarov, Alexander and Kriger, Daria and Kuneev, Ivan and Petukhov, Alexey and Gnennaya, Yulia and Tulchinsky, Eugene and Shuvalov, Oleg and Barlev, Nickolai},
title = {ZEB1 Defines the Interaction Between Breast Cancer Cells and Macrophages by Upregulating the Expression of CCL2 Cytokine},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27209194}
}
EUVIMED